Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Stephens Stick to Their Hold Rating for Amedisys Inc

Published 08/07/2021, 05:03 AM
AMED
-


Stephens analyst Stephens maintained a Hold rating on Amedisys (NASDAQ:AMED) Inc on Friday, setting a price target of $237, which is approximately 23.86% above the present share price of $191.34.

expects Amedisys Inc to post earnings per share (EPS) of $1.52 for the third quarter of 2021.

The current consensus among 7 TipRanks analysts is for a Moderate Buy rating of shares in Amedisys, with an average price target of $258.67.
The analysts price targets range from a high of $320 to a low of $220.

In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $537.14 million and a net profit of $68.85 million. The company's market cap is $6.23 billion.

According to TipRanks.com, Stephens analyst Stephens is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 11.3% and a 58.69% success rate.

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.